Therapeutic N-aryl or N-heteroaryl pyrazolidine and...

Details Therapeutic N-aryl or N-heteroaryl pyrazolidine and... Therapeutic N-aryl or N-heteroaryl pyrazolidine and...

2009-02-17

2009-08-18

Saeed, Kamal A (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S382000, C514S406000, C548S251000, C548S252000, C548S253000, C548S364100

Reexamination Certificate

active

07576112

ABSTRACT:
A compound having a structureand therapeutic methods, compositions, and medicaments related thereto are disclosed herein.

REFERENCES:
patent: 5902726 (1999-05-01), Kliewer et al.
patent: 1481976 (2003-03-01), None
patent: WO 2004/043354 (2004-05-01), None
Baxter, et al., “Synthesis and Use of 7-Substituted Norbornadienes + for the Preparation of Prostaglandins and Prostanoids,” J. Chem. Soc. Perkin Trans., 1986, pp. 889-900.
Dragoli, et al., “Parallel Synthesis of Prostaglandin E1Analogues,” J. Comb. Chem., 1999, 1, pp. 534-539.
Stella, Valentino J, Expert Opinion of Therapeutic Patents, Prodrugs as therapeutics, 2004 14(3): 277-280.
Wolff et al. (Burger's Medicinal Chemistry, 5th Ed., vol. 1, pp. 975-977, 1994)|.
Testa, Bernard, Biochemical Pharmacology, Prodrug Research: futile or fertile? 68 (2004) 2097-2106.
Ettmayer, Peter, Medicinal Chemistry, Lessons Learned from Marketed and Investigational Prodrugs, 47(10)(2004)2394-2404.

Affiliated with

Also associated with

Rating

Therapeutic N-aryl or N-heteroaryl pyrazolidine and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic N-aryl or N-heteroaryl pyrazolidine and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic N-aryl or N-heteroaryl pyrazolidine and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4052478